High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019

The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observat...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Wei, Liu, Xiaosheng, Bai, Tao, Fan, Hongwei, Hong, Ke, Song, Hui, Han, Yang, Lin, Ling, Ruan, Lianguo, Li, Taisheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111600/
https://www.ncbi.nlm.nih.gov/pubmed/32258207
http://dx.doi.org/10.1093/ofid/ofaa102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7111600/
https://www.ncbi.nlm.nih.gov/pubmed/32258207
http://dx.doi.org/10.1093/ofid/ofaa102

Ejemplares similares